Biomedical engineering applies fundamental engineering principles to the study of biology, medicine and health. Our undergraduate program provides a broad background in chemical, mechanical, materials science and electrical engineering, and it prepares students for careers in biomedical research with a quantitative engineering emphasis. It is also designed to provide students with sufficient coursework for advanced training at graduate, medical or physical therapy schools or in other allied health professions. Our graduate program builds upon the established biomedical research strength at the University and trains future generations of researchers and professionals who will play a key role in multi- and interdisciplinary teams that bridge the gap between engineering and the biological sciences.
Dawn Elliott is one of two Orthopaedic Research Society (ORS) members to receive the new ORS Outstanding Achievement in Mentoring Award. This award celebrates the commitment of the outstanding mentors in our community who promote the success of new investigators in the pursuit of independent orthopaedic research careers. It recognizes ORS members who have shown exceptional achievement in mentorship and advocacy on behalf of new investigators in orthopaedic research.
Students and faculty from UD’s Biomedical Engineering Society (BMES) visited the Johns Hopkins University (JHU) campus in Baltimore on Friday, March 27, to participate in the third annual BMES Undergraduate Research Day. Read more.
John Slater has been featured in the alumni profiles of the University of Texas, Austin where he received his PhD. There, he worked in Dr. Wolfgang Frey’s lab to develop nanopatterned surfaces to induce cancer-like behavior, increased proliferation and migration, in non-cancer cells. Read more.
BME grad student Rachel Edelstein received Honorable Mention in the 2015 NSF Graduate Research Fellowship Program (GRFP) competition for her proposed research on utilizing actively targeted nanoparticles coated with antibodies and small interfering RNA for the treatment of Triple Negative Breast Cancer, a form of breast cancer that is ineligible for many conventional treatments because it lacks the appropriate receptors.
Cole Galloway joined 75 other internationally recognized thought leaders at TEDMED 2014, “Unlocking Imagination in Service of Health and Medicine.” He shared the story of the GoBabyGo Program and focused on the importance of independent mobility for children to fully develop cognitively, emotionally and physically. Read more.